Jazz Pharmaceuticals plc — Director's Dealing 2017

Aug 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2017-08-14

Reporting Person: Treacy Paul (SVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-14	Ordinary Shares	S	200	$143.406	Disposed	17489	Direct
2017-08-14	Ordinary Shares	S	1104	$143.3	Disposed	16385	Direct

Footnotes

F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F2: Includes 110 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2017.